ABOUT US
Our scientific and research team

Barcode nanotech's management & researchers and scientists.

pass Ronen BW.jpg
CEO AND CO-FOUNDER
Ronen Eavri, Ph.D. MBA

Leading new product development in pharmaceutical and medical device companies for over 10 years (formally: J&J and D-Pharm) .

Scientific education from the Hebrew University, Technion and MIT.

Annie Sabbah photo
CTO AND CO-FOUNDER
Annie Sabbah, Ph.D.

Former CTO of MPT Diagnostics and Lab Research Manager at Rambam Campus (Technion). Expert in microparticles and molecular biology.

Scientific education from the Technion.

Felix Badinter photo
R&D TEAM LEADER
Felix Badinter M.Sc.

M.Sc. in Biotechnology from the Technion. 


Over 8 years of industrial experience in Research and Development in the fields of biotech and nanotechnology.

Valeria Rukhman photo
ANALITICAL CHEMISTRY LEAD
Valeria Rukhman Ph.D.

Ph.D. in Biochemistry from the faculty of Chemistry of the Technion. 


Over 15 years of experience in pharmaceutical QC laboratories. 

WhatsApp Image 2021-10-19 at 20.52.23.jpeg
SCIENTIST
Or Rosen M.Sc.

M.Sc. in Biotechnology from the Tel-Hai.


Experienced in various chemical and biological processes.

ABOUT US
Scientific Advisory Board

Experts in nanotechnology with global experience.

INVENTOR AND CO-FOUNDER
Avi Schroeder Ph.D.

Associate  Professor, Faculty of Chemical Engineering at the Technion. Prof. Schroeder is Head of the Targeted Drug Delivery and Personalized Medicine Technologies Laboratory at the Technion.

Co-founder and inventor - ViAqua Therapeutics, Moebius Medical, InPlant, and PEEL Therapeutics.

ADVISORY BOARD
Yechezkel Barenholz Ph.D.

Professor of Biochemistry at the Hebrew University of Jerusalem. He is on the Editorial Boards of "Chemisty and Physics of Lipids" and the "Journal of Liposome Research". Prof. Barenholz has over 300 publications and over 30 patents

 

Inventor of the first FDA-approved liposomal medicine and founder of several prominent startups.

ABOUT US
Medical Advisory Board

Clinical experts 

MEDICAL ADVISOR
Beatrice Uziely M.D. MPH

Head, Ambulatory Services Unit, Sharett Institute of Oncology, Hadassah. She is a leading mammalogy oncologist and is one of the most well-known experts in the field of treatment of breast cancer.

 

Received her MD from the Hebrew Univeristy in Jerusalem.

MEDICAL ADVISOR
Shai Rosenberg M.D. Ph.D.

Senior Neurologist, Neuro-Oncologist, and Head of Cancer Computational Biology Lab at Hadassah Medical Center. Expert in computational biology and cancer genomics.

M.D. and Ph.D. in statistical genetics from the Technion.

ABOUT US
Board Members

Our board members founded and managed various biotech companies.

BOARD MEMBER
Ei Yamada Ph.D.

President and CEO of AnGes, Inc., a leading biopharma company specializing in gene therapy. Is also the current CEO of AnGes Euro Ltd. and AnGes USA, Inc.

Former director at Takaro Shuzo Co. and various roles at Sosei K.K. and Mitsubishi Kasei Corporation.

BOARD MEMBER
Aharon Schwartz Ph.D.

Former Vice President, Head of Teva Innovative Ventures. Current Director of Protalix Biotherapeutics. He is currently the chairman of the board of BioLineRx Ltd. and a member of the board of Foamix Pharma Ltd.

Aharon received his Ph.D. in organic chemistry from the Weizmann Institute of Science.

BOARD MEMBER
Zohar Gendler

CEO and Managing Partner of NGT3VC. Former CEO and director of Beta-O2 Technologies. Served as CEO of the Technion Entrepreneurial Incubator (TEIC)  for 11 years.

 

Zohar led the establishment and investment in more than 50 companies including Prolor Biotech, Mazor Robotics, ReWalk, Corindus, Regentis and many others.

BOARD MEMBER
Ron Laufer M.D. MPH

Co-founder of Lilly Ventures and Senior Managing Director at Medimmune Ventures. Former Board Member of Adheron, CGI Therapeutics, G1 Therapeutics, and Remon Medical. Adjunct Professor at Kelley School of Business, Indiana University.

Ron received his M.D. and M.P.H. from the Hebrew University and his MBA from Harvard Business School.

BOARD MEMBER
Nili Weitzman Adv. , LLM

Chief Legal Officer at the Technion R&D Foundation for over 15 years. Specializing in intellectual property laws, leading technology transfer agreements and startups based on Technion technologies and inventions.

Nili serves as a director in the board of directors of many Technion related companies for many years.

BOARD MEMBER
Stanley Hirsch Ph.D.

CEO FuturaGene. Formerly:  Chairman – Foamix, Chairman-OWC Pharma; Director- Biological Industries, SolGel Technologies.

Let's talk.

Barcode nanotech is raising capital and looking to partner with medical institutions for further research.